3m biotech straddles (XBI at-the-money) are so expensive that selling them at current pricing would have been profitable 93% of the time going back to 2006 on a hold to maturity basis. I haven't seen a historical Sharpe ratio this high on a sold index straddle in a while. What do you guys think of this? Part of me thinks it's really exciting, the other part is nervous of more of the news flow that has led to the current drop. Would currently collect $13.30 or about 22% of spot.
Found and back-tested this trade using a homegrown app, happy to share it with people if there's interest.
Found and back-tested this trade using a homegrown app, happy to share it with people if there's interest.
Last edited: